2025-11-24 – Weekly Medical Sales News : How many touches for HCP trials?

Last week, our community delved into a range of topics central to the medical sales profession. There was a lively discussion on how many interactions with healthcare professionals (HCPs) are typically required to secure a trial, reflecting on both strategy and frequency. Another conversation explored the transition from brand strategy roles to medical sales, with members sharing valuable personal experiences and insights. Additionally, there was a focus on identifying tools that facilitate quick HCP education offline, highlighting the need for effective resources in environments without internet access.


This Week’s Hot Topics

How many touches to HCP trial
Members are mapping out the ideal number of interactions needed to convince HCPs to trial a product. The consensus seems to be shifting as strategies evolve.
Read more here

From brand strategy to med sales
Transitioning from brand strategy to medical sales can be a rewarding pivot. This thread uncovers the skills and experiences that can ease the switch.
Read more here

Offline-friendly tools for quick HCP education
Finding the right tools to educate HCPs without internet access is crucial. Members are sharing their go-to offline solutions.
Read more here


Feel free to join these discussions or start a new one. Looking forward to hearing your thoughts next week.

When I’m trying to “secure a trial,” touch 3 is my conversion ask: I propose a 12‑minute in‑service with the clinic manager and send a calendar invite plus a one‑page checklist instead of another email. In tighter‑access IDNs it often slips to touch 5–6, but the same specific ask works if you tie it to their next staff huddle. Anyone see better uptake when the coordinator, not the HCP, is the primary contact?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍​​⁠‌​​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​​​⁠​‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌​‌‍‌‌​⁠​‍​‍⁠‌‌​‍‌​⁠​‍‌​‌​‌​⁠‌‌​​⁠‌​​‌‌‍​‌‌​‌‌‌⁠‍​‌‍‌‍‌⁠​⁠‌‍‍⁠​‍​‍‌⁠⁠‌